via University of Cambridge
Researchers trying to turn off a gene that allows cancers to spread have made a surprising U-turn. By making the gene overactive and functional in the hearts of mice, they have triggered heart cell regeneration.
The inability of the heart to regenerate itself is a significant unmet clinical need
Since adult hearts cannot usually repair themselves once damaged, harnessing the power of this gene represents major progress towards the first curative treatment for heart disease.
“This is really exciting because scientists have been trying to make heart cells proliferate for a long time. None of the current heart disease treatments are able to reverse degeneration of the heart tissue – they only slow progression of the disease. Now we’ve found a way to do it in a mouse model,” said Dr Catherine Wilson, a researcher in the University of Cambridge’s Department of Pharmacology, who led the study.
The cell cycle – through which cells make copies of themselves – is tightly controlled in mammalian cells. Cancer develops when cells start to replicate themselves uncontrollably, and the Myc gene plays a key role in the process. Myc is known to be overactive in the vast majority of cancers, so targeting this gene is one of the highest priorities in cancer research. Much recent research has focused on trying to take control of Myc as a means of cancer therapy.
When the researchers made Myc overactive in a mouse model, they saw its cancerous effects in organs including the liver and lungs: huge amount of cells started replicating over the course of a few days. But in the heart, nothing much happened.
They found that Myc-driven activity in heart muscle cells is critically dependent on the level of another protein called Cyclin T1, made by a gene called Ccnt1, within the cells. When the Ccnt1 and Myc genes are expressed together, the heart switches into a regenerative state and its cells start to replicate. The results are published today in the journal Nature Communications.
“When these two genes were overexpressed together in the heart muscle cells of adult mice we saw extensive cell replication, leading to a large increase in the number of heart muscle cells,” said Wilson.
Heart failure affects around 23 million people worldwide each year, and there is currently no cure. After a heart attack, an adult human heart can lose up to one billion heart muscle cells – called cardiomyocytes. Unlike many other organs in the body, the adult heart can’t regenerate itself, so these cells are never replaced. Their loss reduces the strength of the heart and causes scar formation, heart failure and ultimately death.
Using a next generation sequencing technology called ChIP, the researchers were able to watch the action of Myc in the heart cells. Myc produces a protein – called a transcription factor – that binds to the DNA in specific cells and activates gene expression. But despite the protein binding successfully, the heart cells didn’t start to replicate themselves because the protein could not activate gene expression. Another protein vital to gene expression, Cyclin T1, was deficient in the heart. Adding it to the cells with the overactive Myc caused the cells to start proliferating.
“None of the current treatment options can reverse the degeneration of heart tissue. The inability of the heart to regenerate itself is a significant unmet clinical need,” said Wilson. “We found that even when Myc is switched on in a heart, the other tools aren’t there to make it work, which may be one of the reasons heart cancer is so extremely rare. Now we know what’s missing, we can add it and make the cells replicate.”
As the world’s population grows and the prevalence of heart failure increases, the cost of patient care is anticipated to increase dramatically. The researchers hope to develop their finding into a genetic therapy for the treatment of heart disease. “We want to use short-term, switchable technologies to turn on Myc and Cyclin T1 in the heart. That way we won’t leave any genetic footprint that might inadvertently lead to cancer formation,” said Wilson.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Heart cell regeneration
- Stem cell expert lays bare how people can lead active disease-free lives until 100
A STEM CELL expert has laid bare how harnessing the power of the body's arsenal of stem cells could lead to people enjoying active, healthy lifestyles up to the age of 100.
- Rebuttal to “Embryonic stem cell-derived cardiac myocytes are not ready for human trials”, by Anderson et al, Circ Res. 2014 Jul 18;115(3):335-8
Our group recently reported a proof-of-concept study showing that human embryonic stem cell-derived cardiomyocytes (hESC-CMs) can regenerate significant myocardium in the infarcted hearts of non-human ...
- Validation of the Cardiosphere Method to Culture Cardiac Progenitor Cells from Myocardial Tissue
At least four laboratories have shown that endogenous cardiac progenitor cells (CPCs) can be grown directly from adult heart tissue in primary culture, as cardiospheres or their progeny ...
- Regenerating Cells That Propagate Heartbeats
Specialized cells that propagate heartbeats have the capacity to regenerate after birth, study by UT Southwestern scientists shows. Specialized cells that conduct electricity to keep the heart beating ...
- Specialized cells that keep the heart beating have ability to regenerate after birth, study reveals
Specialized cells that conduct electricity to keep the heart beating have a previously unrecognized ability to regenerate in the days after birth, a new study in mice by UT Southwestern researchers ...
Go deeper with Google Headlines on:
Heart cell regeneration
Go deeper with Bing News on:
Curative treatment for heart disease
- 500 rallied in Travis for little Reed to find cure for the 4-year-old afflicted with a rare genetic disorder
One of the most effective methods to raise awareness about a child’s health disorder is to seek community assistance to raise funds to further research, as well as assist the families. So after 4 year ...
- CURATIVE BIOTECHNOLOGY ANNOUNCES DR. CATHERINE SOHN AS SPECIAL ADVISOR TO BOARD AND CEO
Dr. Sohn to Oversee Development of Next Gen COVID-19 Vaccine to Treat Kidney Failure Patients, Late-Stage Rabies Therapeutic and Age-related Macular ...
- Young Largo Mother Copes With Fatal Disease With Family's Support
A Largo family is hosting a golf tournament to raise funds for research into Huntington's disease, a fatal brain disease that has no cure.
- How the Cure for Herpes Became Mired in Controversy. The latest chapter in the battle between Big Pharma and Synergy Pharmaceuticals
Synergy Pharmaceuticals is one such company currently facing pushback from the FDA. Its name is a bit confusing considering that its catalog features only natural vitamins. Even more confusing is that ...
- Offsetting the Increased Cost of AD Treatment
Key opinion leaders discuss possible ways to mitigate the increased cost of Alzheimer disease treatment. Neil Minkoff, MD: As we start thinking about it from a societal as well as a health care point ...